With the analysis among 89,418 patents, we discovered top 476 key players by total patent application. F. Hoffmann-La Roche Ltd., Novartis AG, AstraZeneca Pharmaceutical Co., Ltd. are dominant in this area. They take 9.56% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Basel-Stadt, Switzerland
Patent: 3,116
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2,277
New York, United States
Patent: 1,772
New York, United States
Patent: 1,402
Indiana, United States
Patent: 1,246
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1,053
Antwerpen, Belgium
Patent: 1,043
California, United States
Patent: 757
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 747
With the analysis among 3,053 patents, we discovered top 358 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Shenzhen Tajirui Biomedical Co. Ltd., Cellix Bio Pvt Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 155
Telangana, India
Patent: 113
Prilenia Therapeutics Development Ltd.
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 71
Nocion Therapeutics, Inc.
Massachusetts, United States
Patent: 67
Cambridgeshire, United Kingdom
Patent: 54
Essex, United Kingdom
Patent: 52
TransThera Sciences (Nanjing), Inc.
Jiangsu Sheng, China
Patent: 49
With the analysis among related 51,156 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Novartis AG, Eli Lilly & Co., F. Hoffmann-La Roche Ltd. take 4.81% of patent filing during this period.
Basel-Stadt, Switzerland
Patent: 1,190
Indiana, United States
Patent: 642
F. Hoffmann-La Roche Ltd.
New York, United States
Patent: 624
Nanjing Mingde New Drug Research and Development Co., Ltd.
Jiangsu Sheng, China
Patent: 545
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 501
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 474
New York, United States
Patent: 457
California, United States
Patent: 424
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 377
With the analysis among related 51,156 patents in last 5 years, we discover 87 new entrants. Wigen Biomedicine technology (Shanghai) Co Ltd, Aligos Therapeutics, Inc., Suzhou Yasheng Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Wigen Biomedicine technology (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 138
Aligos Therapeutics, Inc.
California, United States
Patent: 124
Suzhou Yasheng Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 87
Ascentage Pharma Group Corp. Ltd.
Shanghai Shi, China
Patent: 83
Nocion Therapeutics, Inc.
Massachusetts, United States
Patent: 67
STOCKHOLM, Sweden
Patent: 55
Jiangxi Jemincare Group Co., Ltd.
Jiangxi Sheng, China
Patent: 55
Shanghai Jiyu Pharmaceutical Technology Co Ltd
Shanghai Shi, China
Patent: 53
New York, United States
Patent: 52
Essex, United Kingdom
Patent: 52
With the analysis among 11,176 patents, we discovered top 286 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, China Pharmaceutical University, Shenyang Pharmaceutical University are dominant in this area. They take 9.22% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 361
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 286
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 261
Chinese Academy of Medical Scciences & Peking Union Medical College
Shanghai Shi, China
Patent: 125
Sichuan Sheng, China
Patent: 123
Academy of Military Medical Sciences
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 121
President & Fellows of Harvard College
Massachusetts, United States
Patent: 101
Korea Institute of Science & Technology